Computer-Assisted Cognitive Training for Brain Tumor
Trial Summary
What is the purpose of this trial?
This trial studies how well an adaptive computer-based training program works for younger patients with brain tumors who have had radiation therapy. The program adjusts its difficulty based on the patient's performance to help improve their memory and attention.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Computer-Assisted Cognitive Training for brain tumor patients?
Research shows that computer-assisted cognitive training can be effective in improving cognitive function in patients with brain tumors and other neurological conditions. A study on the ReMind app, a cognitive rehabilitation program for brain tumor patients, found that most participants rated the program as 'good' or 'excellent' and would recommend it to others, suggesting its potential effectiveness.12345
Is computer-assisted cognitive training safe for humans?
How does Computer-Assisted Cognitive Training differ from other treatments for brain tumors?
Computer-Assisted Cognitive Training is unique because it uses technology to help improve cognitive functions in brain tumor patients, offering a flexible and individualized approach that can be accessed remotely. This treatment focuses on enhancing cognitive skills like attention and memory through interactive exercises, making it more accessible and engaging compared to traditional therapies.145910
Research Team
Kristina K Hardy
Principal Investigator
Children's Oncology Group
Eligibility Criteria
This trial is for young patients with brain tumors who have finished radiation therapy within the last 4 months. They need to have a caregiver, access to a phone, and understand English. Patients with traumatic brain injury before their tumor diagnosis, pontine glioma, IQ < 70 or severe disabilities that prevent computer use are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a home-based, computerized, interactive training program for 5-9 weeks, with 3-5 sessions of 15-45 minutes each week. The program is either adaptive or non-adaptive, depending on the arm.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at baseline, after completion, and at 6 months post-treatment.
Treatment Details
Interventions
- Computer-Assisted Cognitive Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Oncology Group
Lead Sponsor
National Cancer Institute (NCI)
Collaborator